Albumin Excipient Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Albumin Excipient Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Albumin Excipient Market:
https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

According to The Business Research Company’s Albumin Excipient Global Market Report 2024, The albumin excipient market size has grown strongly in recent years. It will grow from $4.56 billion in 2023 to $4.91 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to biopharmaceutical industry growth, increased adoption of biologics, risen prevalence of chronic diseases, clinical advancements and drug innovation, increased focus on drug delivery.

The albumin excipient market size is expected to see strong growth in the next few years. It will grow to $6.32 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to continued biopharmaceutical expansion, growing biologics pipeline, rising geriatric population, global vaccination initiatives, increasing drug development investments. Major trends in the forecast period include biodegradable and biocompatible properties, collaborations and partnerships in research, regulatory compliance and quality standards, application in cell therapy, customization and tailored solutions.

The rising prevalence of chronic diseases is expected to propel the growth of the albumin excipient market going forward. A chronic disease is a form of illness that lasts three months or more and can deteriorate with time. Albumin is used as a blood volumizer and is the most abundant circulating protein in plasma that acts as a versatile protein carrier for drug targeting and for improving the pharmacokinetic profile of peptide or protein-based drugs is involved in the treatment of various diseases, including cancer, and diabetes. For instance, in January 2023, according to The National Center for Biotechnology Information, the US-based National Library of Medicine, which the federal government operates, the number of people in the USA aged 50 and older who have at least one chronic condition would increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the rising prevalence of chronic diseases is driving the growth of the albumin excipient market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp

The albumin excipient market covered in this report is segmented –

1) By Product: Human Serum Albumin, Recombinant Albumin
2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users

Product innovations are a key trend gaining popularity in the albumin excipient market. Major companies operating in the albumin excipient market are introducing innovative solutions to sustain their position in the market. For instance, in November 2021, Grifols, S.A., a Spain-based healthcare company, introduced ALBUTEIN FlexBag (Albumin [Human] U.S.P.) in 5% and 25% concentrations, providing healthcare professionals with a more convenient option. The 5% concentration received U.S. Food and Drug Administration (FDA) approval in July 2021, featuring 250 mL and 500 mL bags, while the 25% concentration, approved earlier in the year, offers 50 mL and 100 mL bags. The ALBUTEIN FlexBag is available in various sizes and presented in an eco-friendly bag without plasticizers, offering a sustainable choice for healthcare professionals.

The albumin excipient market report table of contents includes:

1. Executive Summary
2. Albumin Excipient Market Characteristics
3. Albumin Excipient Market Trends And Strategies
4. Albumin Excipient Market Analysis
5. Albumin Excipient Market Size And Growth
6. Albumin Excipient Segmentation
7. Regional And Country Analysis
.
.
.
27. Albumin Excipient Competitive Landscape And Company Profiles
28. Albumin Excipient Key Mergers And Acquisitions
29. Albumin Excipient Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

• Albumin Therapeutics LLC
• Biotest AG
• CSL Behring
• Grifols S.A.
• HiMedia Laboratories LLC
• InVitria Inc.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model